603858 Shandong Buchang Pharmaceuticals
- 14.73
- +0.12+0.82%
Shandong Buchang Pharmaceuticals News
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on foreign donations
Buchang Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Fifth Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fourth Meeting of the Fifth Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Second Meeting of the Fifth Board of Supervisors of Shandong Buchang Pharmaceutical Co., Ltd.
Special report on the storage and actual use of funds raised in the 2024 semi-year of Shandong Buchang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Third Meeting of the Fifth Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Special legal opinions from Beijing Jindu (Qingdao) Law Firm regarding the differentiated dividends of Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement of the First Meeting Resolution of the Fifth Supervisory Board of Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement of Resolutions of the First Meeting of the Fifth Board of Directors of Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement by Shandong Buchang Pharmaceuticals Co., Ltd. Regarding the Obtaining of Registration Certificate for Wenxin Granules Pharmaceutical in Malaysia.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. regarding Naoxintong Capsule obtaining Hong Kong Chinese Patent Medicine Registration Certificate.
Reply to the regulatory opinions on the information disclosure of Shandong Buchang Pharmaceuticals Co., Ltd.'s 2023 annual report by Ernst & Young Hua Ming LLP (Special General Partnership).
Announcement on the Reply to the Shanghai Stock Exchange's Regulatory Letter on Information Disclosure on the Company's 2023 Annual Report by Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. on its external donations.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. providing guarantees for its subsidiary.
Independent financial advisor report (Revised Draft) of Shandong Buchang Pharmaceuticals Co., Ltd.'s repurchase of shares through centralized bidding trading method, by Daiwa Securities (China) Ltd.
Legal Opinion of Jindu (Qingdao) Law Firm, Peking, regarding the adjustment and repurchase of shares by Shandong Buchang Pharmaceuticals Co., Ltd.
Announcement of Resolutions of the 55th Meeting of the Fourth Board of Directors of Shandong Buchang Pharmaceutical Co., Ltd.
Shandong Buchang Pharmaceutical Co., Ltd. Independent Director Working System
Shandong Buchang Pharmaceutical Co., Ltd. Senior Management Remuneration and Assessment Management Measures
Analysis
Price Target
No Data
No Data